在良性前列腺增生前列腺中识别和功能性活性尼克相关激酶 (NRK)
Weixiang He1, Zelin Tian2, Bingchen Dong3
1Department of Urology, Xijing Hospital of Air Force Medical University, West Changle Road 127, Xi'an, China. hwxmd2021@163.com.
Journal of translational medicine
|March 8, 2024
概括
尼克相关激酶 (NRK) 在良性前列腺激增症 (BPH) 中被上调,并与树皮细胞变化有关. NRK可能是BPH和下泌尿道症状 (LUTS) 的治疗标.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 良性前列腺增生 (BPH) 是老年男性中普遍存在的疾病.
- 识别BPH病变的关键分子参与者对于治疗开发至关重要.
研究的目的:
- 为了识别高增多性前列腺组织中的差异表达基因 (DEGs).
- 研究尼克相关激酶 (NRK) 在BPH发展中的作用.
主要方法:
- 大量和单细胞RNA-seq数据集的综合生物信息学分析.
- 通过RT-PCR,西部斑,免疫组织化学和基于细胞的测定来实验验证NRK表达和功能的验证.
主要成果:
- 发现NRK在纤维细胞和前列腺组织的光滑肌细胞中显著上调.
- NRK表达与BPH严重程度相关 (IPSS,Qmax) 并促进了树皮细胞的增殖,迁移,纤维化和上皮-介质细胞过渡 (EMT).
- NRK的淘汰扭转了这些亲BPH效应,而上皮细胞的过度表达显示了相反的结果.
结论:
- NRK在BPH上调节,在前列腺层细胞生物学中发挥关键作用,包括增殖,细胞亡,细胞周期,迁移,纤维化和EMT.
- NRK代表了管理BPH和相关的下泌尿道症状 (LUTS) 的潜在治疗目标.
更多相关视频
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K


